FALIPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FALIPHARMA
Largest movements
- Cash +€41,069
up €41,069 (+20.3%), from €202,241 to €243,310
mainly Net result for the year (+€47,771) and Current portion of long-term debt (+€42,127)
- Receivables within one year +€20,516
up €20,516 (+29.9%), from €68,652 to €89,169
of which Trade receivables: +€16,637
- Tangible fixed assets -€17,592
down €17,592 (-8.4%), from €210,626 to €193,035
of which Land and buildings: -€13,623
- Debts after one year -€51,026
down €51,026 (-16.7%), from €305,137 to €254,112
of which Other amounts payable: -€41,949
- Profit (loss) carried forward +€47,771
up €47,771 (+68.8%), from €69,404 to €117,175
- Current portion of long-term debt +€42,127
up €42,127 (+473.4%), from €8,899 to €51,026
- Accrued charges and deferred income +€9,719
up €9,719 (+98.6%), from €9,856 to €19,575
- Gross operating margin +€26,404
up €26,404 (+10.9%), from €243,295 to €269,699
- Taxes +€7,515
up €7,515 (+69.3%), from €10,842 to €18,357
- Staff costs +€3,863
up €3,863 (+2.4%), from €157,867 to €161,730
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €681,587 | €731,975 | +€50,389 | +7.4% |
| Fixed assets | 21/28 | €217,072 | €199,480 | -€17,592 | -8.1% |
| Tangible fixed assets | 22/27 | €210,626 | €193,035 | -€17,592 | -8.4% |
| Land and buildings | 22 | €142,143 | €128,521 | -€13,623 | -9.6% |
| Plant, machinery and equipment | 23 | €67,390 | €59,093 | -€8,297 | -12.3% |
| Furniture and vehicles | 24 | €1,093 | €5,421 | +€4,328 | +396.1% |
| Financial fixed assets | 28 | €6,445 | €6,445 | = | 0.0% |
| Current assets | 29/58 | €464,515 | €532,496 | +€67,980 | +14.6% |
| Stocks and contracts in progress | 3 | €189,398 | €193,795 | +€4,397 | +2.3% |
| Stocks | 30/36 | €189,398 | €193,795 | +€4,397 | +2.3% |
| Amounts receivable within one year | 40/41 | €68,652 | €89,169 | +€20,516 | +29.9% |
| Trade receivables | 40 | €68,652 | €85,290 | +€16,637 | +24.2% |
| Other amounts receivable | 41 | €0 | €3,879 | +€3,879 | |
| Current investments | 50/53 | - | €7 | +€7 | |
| Cash at bank and in hand | 54/58 | €202,241 | €243,310 | +€41,069 | +20.3% |
| Deferred charges and accrued income | 490/1 | €4,224 | €6,215 | +€1,991 | +47.1% |
| Total equity and liabilities | 10/49 | €681,587 | €731,975 | +€50,389 | +7.4% |
| Equity | 10/15 | €277,007 | €324,777 | +€47,771 | +17.2% |
| Contributions | 10/11 | €19,000 | €19,000 | = | 0.0% |
| Reserves | 13 | €188,603 | €188,603 | = | 0.0% |
| Distributable reserves | 133 | €188,603 | €188,603 | = | 0.0% |
| Profit (loss) carried forward | 14 | €69,404 | €117,175 | +€47,771 | +68.8% |
| Amounts payable | 17/49 | €404,580 | €407,198 | +€2,618 | +0.6% |
| Amounts payable after more than one year | 17 | €305,137 | €254,112 | -€51,026 | -16.7% |
| Financial debts | 170/4 | €110,438 | €101,361 | -€9,076 | -8.2% |
| Other amounts payable | 178/9 | €194,700 | €152,750 | -€41,949 | -21.5% |
| Amounts payable within one year | 42/48 | €89,587 | €133,511 | +€43,925 | +49.0% |
| Current portion of amounts payable after more than one year | 42 | €8,899 | €51,026 | +€42,127 | +473.4% |
| Trade debts | 44 | €34,480 | €37,419 | +€2,939 | +8.5% |
| Suppliers | 440/4 | €34,480 | €37,419 | +€2,939 | +8.5% |
| Taxes, remuneration and social security | 45 | €35,554 | €34,322 | -€1,232 | -3.5% |
| Taxes | 450/3 | €13,257 | €11,551 | -€1,706 | -12.9% |
| Remuneration and social security | 454/9 | €22,298 | €22,771 | +€474 | +2.1% |
| Other amounts payable | 47/48 | €10,654 | €10,744 | +€90 | +0.8% |
| Accrued charges and deferred income | 492/3 | €9,856 | €19,575 | +€9,719 | +98.6% |
| Remuneration, social security and pensions | 62 | €157,867 | €161,730 | +€3,863 | +2.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €22,732 | €23,435 | +€703 | +3.1% |
| Other operating charges | 640/8 | €5,053 | €4,795 | -€259 | -5.1% |
| Gross operating margin | 9900 | €243,295 | €269,699 | +€26,404 | +10.9% |
| Operating profit (loss) | 9901 | €57,643 | €79,739 | +€22,096 | +38.3% |
| Financial income | 75/76B | €1,719 | €2,014 | +€295 | +17.2% |
| Recurring financial income | 75 | €1,719 | €2,014 | +€295 | +17.2% |
| Financial charges | 65/66B | €15,848 | €15,625 | -€223 | -1.4% |
| Recurring financial charges | 65 | €15,848 | €15,625 | -€223 | -1.4% |
| Profit (loss) for the period before taxes | 9903 | €43,514 | €66,128 | +€22,614 | +52.0% |
| Income taxes | 67/77 | €10,842 | €18,357 | +€7,515 | +69.3% |
| Profit (loss) for the period | 9904 | €32,672 | €47,771 | +€15,099 | +46.2% |
| Profit (loss) for the period to be appropriated | 9905 | €32,672 | €47,771 | +€15,099 | +46.2% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.